Additionally, Liu et al. utilized MAPK inhibitors to significantly reduce the expression level of FGL2 in CAC cells and FGL2 ameliorated the invasion and migration of CRC cells 85. The gene discussed is FGL2; the disease is colorectal carcinoma.